VCAM1 and metabolic dysfunction-associated steatotic liver disease: Interestingly, Lefere et al. reported that serum VCAM-1 levels predicted hepatic fibrosis in patients with NAFLD, indicating a potential role of VCAM-1 in the fibrotic pathogenesis of NASH [22].